Table 5.
Comparison of the recurrent P. vivax genotypes
| |
Pregnant women |
Non-pregnant women |
p-value* |
|---|---|---|---|
| N = 62 | N = 54 | ||
| No. of recurrent Plasmodium vivax infections |
44 |
36 |
0.617 |
| Median number of recurrences (range) |
2 (2–4) |
2 (2) |
0.221 |
| 1st recurrence and admission episode similar |
3/18 |
6/18 |
0.137 |
| 1/18 B | |||
| 2nd recurrence and admission episode similar |
5/18 |
5/18 |
0.167 |
| 1/18 A | |||
| 3rd recurrence and admission episode similar |
3/6 |
− |
− |
| 4th recurrence and admission episode similar |
1/2 |
− |
− |
| 2nd and 1st recurrence episodes similar |
7/18 |
5/18 |
0.729 |
| 1/18 B | |||
| 3rd and 1st recurrence episodes similar |
2/6 |
− |
− |
| 3rd and 2nd recurrence episodes similar |
3/6 |
− |
− |
| 4th and 1st recurrence episodes similar |
1/2 |
− |
− |
| 4th and 2nd recurrence episodes similar |
1/2 |
− |
− |
| 4th and 3rd recurrence episodes similar |
1/2 |
− |
− |
| Proportion of genotypically similar recurrences |
27/80 |
19/54 |
0.864 |
| In genotypically different recurrence Median proportion of different alleles (%, rang) |
62.50% |
58.60% |
0.562 |
| (range 12.5-100%) | (range 12.5-100%) |
Criteria for interpretation: A = 1 or 2 markers (loci) different with ≤1 possible stepwise mutation; B = 3 markers (loci) different but ≤1 repeat unit, different with ≤1 possible stepwise mutation.
* Chi-square test used to compare in two patients groups.